Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotoxins].

F K Jansen, H E Blythman, D Carrière

    Bulletin Du Cancer
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Observed-to-expected lung-area-to-head-circumference ratio on ultrasound examination vs total fetal lung volume on magnetic resonance imaging in prediction of survival in fetuses with left-sided diaphragmatic hernia.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
    Same author

    Simultaneously measuring the dichroism and the dielectric response of an azobenzene-doped organic glass former.

    The Review of scientific instruments·2023
    Same author

    Priority setting in the German healthcare system: results from a discrete choice experiment.

    International journal of health economics and management·2023
    Same author

    Can risk rating increase the ability of voluntary deductibles to reduce moral hazard?

    The Geneva papers on risk and insurance. Issues and practice·2021
    Same author

    Mortality and morbidity of preterm neonates weighing less than 750g: A 2-year retrospective cohort study.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
    Same author

    Highly sensitive electrochemiluminescence detection of a prostate cancer biomarker.

    Journal of materials chemistry. B·2020
    Same journal

    [ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

    Bulletin du cancer·2026
    Same journal

    [Off-label use of venetoclax in myeloma].

    Bulletin du cancer·2026
    Same journal

    [Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

    Bulletin du cancer·2026
    Same journal

    Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

    Bulletin du cancer·2026
    Same journal

    [Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

    Bulletin du cancer·2026
    Same journal

    [Reirradiation: A new therapeutic paradigm in oncology].

    Bulletin du cancer·2026
    See all related articles

    Immunotoxins, antibody-toxin conjugates, show high cancer cell killing in vitro. While less potent in vivo, they hold promise for future clinical applications like leukemia bone marrow purging.

    Area of Science:

    • Biotechnology
    • Oncology
    • Immunology

    Context:

    • Immunotoxins combine antibodies targeting cancer cells with potent toxins.
    • The study focuses on the A-chain of ricin as the toxic component.

    Purpose:

    • To evaluate the efficacy of immunotoxins against cancer cells.
    • To assess the in vitro and in vivo performance of these conjugates.

    Summary:

    • Immunotoxins demonstrated high specific cytotoxicity against clonogenic cancer cells in vitro, destroying over 99.99%.
    • In vivo efficacy was observed but was less potent compared to in vitro results.

    Impact:

    • Immunotoxins show potential for clinical applications, particularly in purging leukemic cells from bone marrow.
  • Further research may optimize in vivo delivery and efficacy for broader therapeutic use.